High HIV incidence among MSM prescribed postexposure prophylaxis, 2000-2009: indications for ongoing sexual risk behaviour.
about
Preparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxisSources of HIV infection among men having sex with men and implications for preventionDifferentiating Nonoccupational Postexposure Prophylaxis Seroconverters and Non-Seroconverters in a Community-Based Clinic in Los Angeles, California.Design of a syndemic based intervention to facilitate care for men who have sex with men with high risk behaviour: the syn.bas.in randomized controlled trialSubsequent HIV infection among men who have sex with men who used non-occupational post-exposure prophylaxis at a Boston community health center: 1997-2013Longitudinal trends in HIV nonoccupational postexposure prophylaxis use at a Boston community health center between 1997 and 2013.The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV PreventionAdherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort.Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.Adherence to post-exposure prophylaxis for non-forcible sexual exposure to HIV: a systematic review and meta-analysis.Health and budget impact of combined HIV prevention - first results of the BELHIVPREV model.Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens.PEPSE and coke: should we be increasing awareness of HIV post-exposure prophylaxis for consensual risk exposures?2016 United Kingdom national guideline on the sexual health care of men who have sex with men.
P2860
Q26820865-56DCDD4F-0E02-47F0-828D-39B8DB8309E4Q28601386-EB93BA90-EA8E-465F-B490-AD70D795629FQ33762128-E83088A9-F05D-4083-9397-9AF77AF8912AQ33771683-4E178E2B-8A10-4835-98C4-EB91B54A4EC3Q34802731-7173BE4C-DC8F-4260-830E-47DA8000CB84Q35696557-C97D6239-462C-428F-BA15-6F35AAF79F32Q35821208-4CFB47C2-1313-43BF-9F2B-E4EC780E9363Q35838930-8B5E7380-E79D-4A0F-B52B-7FCCEFDF804AQ35999008-FA006542-AC09-44F5-B9D1-864C36CDA69CQ37395830-92006F27-DF06-446C-97FC-34C66AFBCFB5Q38695854-5BEA25D3-A663-4C64-9F3F-1D5F6E392F9EQ40127599-0A144822-EFBD-4EDC-9477-546E3CADF0C5Q44485509-9D7660F2-1498-4C44-A297-A42F732FEA45Q47553525-E0F6D27E-7F44-4392-8873-7E93AC962C36
P2860
High HIV incidence among MSM prescribed postexposure prophylaxis, 2000-2009: indications for ongoing sexual risk behaviour.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
High HIV incidence among MSM p ...... ongoing sexual risk behaviour.
@en
type
label
High HIV incidence among MSM p ...... ongoing sexual risk behaviour.
@en
prefLabel
High HIV incidence among MSM p ...... ongoing sexual risk behaviour.
@en
P2093
P1433
P1476
High HIV incidence among MSM p ...... ongoing sexual risk behaviour.
@en
P2093
Anneke van den Hoek
Gerard J B Sonder
José Heuker
Ronald Geskus
P304
P356
10.1097/QAD.0B013E32834F32D8
P407
P577
2012-02-01T00:00:00Z